Dataset
4-Androstene-3,17-dione
Chemical Info
InChI | InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1 |
---|---|
SMILES | [H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C |
InChI Key | AEMFNILZOJDQLW-QAGGRKNESA-N |
Molecular Formula | C19H26O2 |
Exact Mass | 286.193 g/mol |
Data and Resources
Metadata Information
Field | Value |
---|---|
DOI | |
License URL | https://creativecommons.org/licenses/by/4.0 |
Source | https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-LCSB-LU039601 |
Version | |
Author | |
Maintainer | |
Language | |
MetadataCreated | 2024-01-11T18:28:00.220159 |
MetadataModified | 2025-02-09T14:56:40.102477 |
MetadataPublished | 2020-08-19 |
Field | Value |
---|---|
Measurement Technique | liquid chromatography-mass spectrometry |
Measurement Variables |
Data-Source Molecule ID | Data-Source |
---|---|
15962866 | PubChem: Thomson Pharma |
14775551 | PubChem: Thomson Pharma |
60020994 | NMRShiftDB |
PD008797 | ProbesDrugs |
LSM-5464 | LINCS |
andrstndn | Recon |
104534-78-3 | ACToR |
63-05-8 | ACToR |
409J2J96VR | FDA SRS |
477820 | eMolecules |
63055 | Brenda |
7119 | Brenda |
4682 | Brenda |
175594 | Brenda |
1186 | Brenda |
12426 | Brenda |
1319 | Brenda |
2262 | Brenda |
92444 | Brenda |
HMDB0000053 | Human Metabolome Database |
16422 | Rhea |
androstenedione | DailyMed |
CB8365581 | ChemicalBook |
ZINC000004428526 | ZINC |
MTBLC16422 | Metabolights |
8046 | Brenda |
MCULE-8902385122 | Mcule |
6128 | PubChem |
SCHEMBL23272 | SureChEMBL |
CHEMBL274826 | ChEMBL |
ASD | PDBe |
DB01536 | DrugBank |
C00280 | KEGG Ligand |
16422 | ChEBI |
SLM:000001060 | SwissLipids |
217865 | Brenda |
ANDROSTENEDIONE | DailyMed |
ANDROSTENEDIONE | rxnorm |
ANDROSTENEDIONE | clinicaltrials |
91713 | BindingDB |
215 | DrugCentral |
LMST02020007 | LipidMaps |
J38.388K | Nikkaji |
2860 | Guide to Pharmacology |
ANDSEO | CCDC |
DTXSID8024523 | EPA CompTox Dashboard |
The data in this table is sourced from UniChem at EBI. |